• This latest research builds upon the growing body of evidence demonstrating the unique impact of Brainomix's AI-powered software to…
OSLO, Norway, Feb. 4, 2025 /PRNewswire/ -- The Norwegian browser maker Opera [NASDAQ: OPRA] is introducing Opera Air, the first browser…
ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced…
Acceptance reflects the high interest of the SIR scientific committee on the emerging role of endovascular roboticsBRAINTREE, Mass., Feb. 04,…
Nearly three million members of the largest health insurance plan in Massachusetts are now eligible for reimbursement when prescribed with…
Vancouver, British Columbia--(Newsfile Corp. - February 4, 2025) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), (the "Company"…
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety…
HOUSTON, TX, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader…